NCT02445391 2026-03-13
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT03281954 2024-04-08
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
NSABP Foundation Inc
Phase 3 Active not recruiting
NCT00022516 2016-09-16
22-00
ETOP IBCSG Partners Foundation
Phase 3 Completed